1. Home
  2. UPBD vs AVDL Comparison

UPBD vs AVDL Comparison

Compare UPBD & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • AVDL
  • Stock Information
  • Founded
  • UPBD 1986
  • AVDL 2015
  • Country
  • UPBD United States
  • AVDL Ireland
  • Employees
  • UPBD N/A
  • AVDL N/A
  • Industry
  • UPBD Diversified Commercial Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPBD Consumer Discretionary
  • AVDL Health Care
  • Exchange
  • UPBD Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • UPBD 1.7B
  • AVDL 1.4B
  • IPO Year
  • UPBD 1995
  • AVDL 1996
  • Fundamental
  • Price
  • UPBD $32.99
  • AVDL $11.66
  • Analyst Decision
  • UPBD Buy
  • AVDL Strong Buy
  • Analyst Count
  • UPBD 6
  • AVDL 6
  • Target Price
  • UPBD $39.17
  • AVDL $24.00
  • AVG Volume (30 Days)
  • UPBD 427.5K
  • AVDL 1.6M
  • Earning Date
  • UPBD 10-31-2024
  • AVDL 11-12-2024
  • Dividend Yield
  • UPBD 4.47%
  • AVDL N/A
  • EPS Growth
  • UPBD 833.06
  • AVDL N/A
  • EPS
  • UPBD 1.49
  • AVDL N/A
  • Revenue
  • UPBD $4,259,426,999.00
  • AVDL $138,160,000.00
  • Revenue This Year
  • UPBD $9.86
  • AVDL $533.23
  • Revenue Next Year
  • UPBD $4.13
  • AVDL $73.08
  • P/E Ratio
  • UPBD $21.53
  • AVDL N/A
  • Revenue Growth
  • UPBD 7.43
  • AVDL 1523.50
  • 52 Week Low
  • UPBD $26.50
  • AVDL $10.41
  • 52 Week High
  • UPBD $38.72
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 60.08
  • AVDL 40.12
  • Support Level
  • UPBD $31.63
  • AVDL $10.41
  • Resistance Level
  • UPBD $32.76
  • AVDL $16.66
  • Average True Range (ATR)
  • UPBD 1.06
  • AVDL 0.88
  • MACD
  • UPBD 0.09
  • AVDL -0.39
  • Stochastic Oscillator
  • UPBD 69.94
  • AVDL 20.00

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Share on Social Networks: